Saw palmetto shows weak, inconsistent benefit in small studies. The single head-to-head trial vs finasteride favored finasteride on every measure. If you want DHT inhibition for hair loss, the evidence supports finasteride or dutasteride — not the natural alternative.
What we recommend instead
Finasteride 1mg
DHT blocker. Strongest prevention evidence — discuss side-effect profile.
Read the verdictSaw palmetto (Serenoa repens) is a palm extract used as the headline ingredient in many 'natural hair growth' supplements. It is marketed as a DHT-blocker and finasteride alternative. Limited evidence shows mild 5-alpha-reductase inhibition, but at far lower potency than finasteride. Head-to-head trials show finasteride is clinically superior.
Satisfied
n=96
₹400–1,200/mo
Monthly cost
9
Peer-reviewed studies
Evidence · what we looked at
9
Peer-reviewed
3,400
Consumer reports
Key findings
How it works
Claim: inhibits 5-alpha-reductase, reducing DHT (the hormone that miniaturizes scalp follicles) — same mechanism as finasteride. Reality: in vitro inhibition is real but weak (~30% at high concentrations vs finasteride's ~70% at therapeutic doses); in vivo effect on scalp DHT is modest and inconsistent.
Dosage: 320 mg orally once daily
If this doesn't fit
Oral · Generic
DHT blocker. Strongest prevention evidence — discuss side-effect profile.
₹300–600/mo
Monthly
78%
Satisfied · n=412
Oral · Avodart
Stronger than finasteride. Off-label for AGA; physician-supervised only.
₹900–1,800/mo
Monthly
74%
Satisfied · n=156
Topical · Generic
The most-studied topical. Works; requires daily commitment.
₹400–800/mo
Monthly
72%
Satisfied · n=380
Safety · side effects
GI upset / nausea
CommonMildMild headache
UncommonMildTheoretical hormonal effects (less studied than finasteride)
RareModerateLong-term safety profile not characterized
Safety notes
Formulation
Serenoa repens extract
Active (weak 5α-reductase inhibitor)
320 mg
Lipid carrier
Excipient
—
Real-world journey mentions
Anonymized cohort timelines where Saw Palmetto was part of the patient's documented regimen. Linkage is patient-disclosed, not inferred from purchases.
We don't fabricate product-journey linkages. Once our first cohort of patient journeys is published, this section will show real timelines that explicitly used this product as part of their documented regimen.
How journeys get verifiedWhen to consult a doctor
The Hair Library is research-first, not a replacement for clinical judgment. A dermatologist or trichologist can rule out medical causes in a single visit — and that visit often saves months of inappropriate treatment.
Hair loss started suddenly or in patches.
Sudden onset or coin-shaped bald patches suggest alopecia areata or telogen effluvium — both medical, neither helped by topical minoxidil alone.
You're under 21 or over 60.
Outcomes and side-effect profiles change at the edges of the age range. A clinician should rule out hormonal or systemic causes.
You have visible scalp inflammation, sores, or scaling.
Seborrheic dermatitis, psoriasis, scarring alopecia and scalp infections need treatment first — products won't help and may worsen them.
No visible improvement after 6 months of consistent use.
If you've been compliant for 24+ weeks with no change, it's time to re-evaluate the diagnosis — not just switch products.
The Hair Library is an independent aggregator. Content is for educational purposes only and is not medical advice. Results vary by patient, technique, and clinician. Always consult a qualified hair-restoration physician before making treatment decisions. Review counts and audit dates are disclosed on every clinic page.
